ClinicalTrials.Veeva

Menu

Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making

U

University Hospital Bonn (UKB)

Status and phase

Completed
Phase 1

Conditions

Healthy Male Volunteers

Treatments

Drug: Oxytocin

Study type

Interventional

Funder types

Other

Identifiers

NCT01607970
OXT-168/11

Details and patient eligibility

About

The purpose of this study is to determine whether oxytocin affects the modulation of startle reactivity by aversive social stimuli and to investigate the oxytocin effect on moral judgements. Furthermore the investigators explore the effects of oxytocin receptor (OXTR) polymorphisms on behavioral responses to social stimuli.

Full description

The neuropeptide oxytocin (OXT) can enhance the impact of positive social cues but may reduce that of negative ones, although it is unclear whether the latter causes blunted emotional responses. After OXT or placebo application participants are exposed to acoustic startle probes presented alone and during viewing of 60 color pictures mostly selected from the 'International Affective Picture System'. The paradigm featured 20 negative (mostly threatening), 20 neutral, and 20 positive pictures, presented for 5 s each. In the other part of the experiment, after intranasal OXT or placebo application participants respond to 60 moral dilemmas.

Enrollment

80 patients

Sex

Male

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy male volunteers

Exclusion criteria

  • Current or past psychiatric disease
  • Current or past physical illness
  • Psychoactive medication
  • Tobacco smokers

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

80 participants in 2 patient groups, including a placebo group

Oxytocin
Experimental group
Description:
24 IU Oxytocin, intranasal application 45 min prior to the experiment
Treatment:
Drug: Oxytocin
Placebo
Placebo Comparator group
Description:
intranasal application, sodium chloride solution, 3 puffs per nostril
Treatment:
Drug: Oxytocin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems